Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

TiGenix NV TIG Financial and Strategic SWOT Analysis Review Report Updated 13112017 Prices from USD $300

$
0
0
SummaryTiGenix NV TiGenix is a biopharmaceutical company that develops and commercializes novel therapeutics. Its product portfolio includes AlloCSC01 AlloCSC02 Cx611 and Cx601. The company develops its products using expanded stem cells extracted from adi...

Viewing all articles
Browse latest Browse all 2985

Trending Articles